First Ebola Vaccine Granted Conditional Approval

The European Commission has approved the first Ebola vaccine, Servo, which is 97.5% effective for adults. Ebola symptoms include fever and hemorrhaging, spreading through bodily fluids. The virus has killed over 13,000 in Africa since 2013. Merck's CEO highlights the vaccine's development as a global scientific milestone. Over 250,000 doses are used in the Congo's current outbreak, with over 3,000 cases and 2,100 deaths, marking it as the largest outbreak since 2013-2016.

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF